The PCR-based point-of-care assays, which return results within 20 minutes, have received regulatory approval from the US Food and Drug Administration earlier this year.

NEW YORK – Abbott last week received 510(k) clearance from the US Food and Drug Administration for its self-collected molecular test for sexually transmitted infections.

This manuscript describes the role of the production of c-di-AMP on the chlamydial developmental cycle ... Strengths: This laboratory is a leader in the use of molecular genetic manipulation in ...